Po-Ren Hsueh

26PUBLICATIONS
42CO-AUTHORS
Infectious agentsCancer therapy (excl. chemotherapy and radiation therapy)Formal methods for softwareNanotoxicology, health and safetyQuality assurance, chemometrics, traceability and metrological chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 13, 2026
Cefiderocol nonsusceptibility among carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: data from the 2024 Antimicrobial Testing Leadership and Surveillance (ATLAS) program.

|Apr 22, 2026
Rituximab, Acalabrutinib, and Durvalumab for Primary Central Nervous System Lymphoma: A Single-Arm, Phase Ib, Multicenter Study.

|Feb 23, 2026
SARS-CoV-2 Main Protease Activates ERK1/2 Signaling to Facilitate MEG2-STAT3-Mediated Suppression of ACE2.

Uyen Nguyen Phuong Le, Ruey-Hwang Chou, Chen-Sheng Lin

|Feb 18, 2026
In vitro activity of aztreonam-avibactam and distribution of carbapenemase genes in ceftazidime-avibactam-resistant carbapenem-resistant Enterobacterales: data from the global Antimicrobial Testing Leadership and Surveillance, 2019-2023.

Yu-Lin Lee, Wei-Yao Wang, Yu-Tsung Huang

|Dec 26, 2025
Evaluation of the GeneTex U-OK SARS-CoV-2 Neutralizing Antibody Detection Assay: Comparison With GenScript cPass and Viral Neutralization Assays.

Hui-Ju Lin, Wen-Chi Su, Hsu-Yu Wen

|Dec 10, 2025
Interpretive agreement of susceptibility between broth microdilution and disk diffusion methods for cefiderocol, using criteria from the Clinical and Laboratory Standards Institute, European Committee on Antimicrobial Susceptibility Testing, and the Food and Drug Administration.

Yu-Tzu Lin, Hsiu-Hsien Lin, Chih-Hao Chen

Pageof 5

Frequent Collaborators

3 joint publications

Chih-Cheng Lai

2 joint publications

Chao-Nan Lin

2 joint publications

Jung-Yien Chien

2 joint publications

Yu-Tsung Huang